Australia PBS Adds RU486, Three Cancer Drugs To Subsidy List
This article was originally published in PharmAsia News
Australia's Pharmaceutical Benefits Scheme has decided to subsidize another $1 billion worth of drugs, including a controversial contraceptive and three costly cancer treatments.
You may also be interested in...
In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.
Concern and skepticism about Russia's rapid vaccine roll-out. Meanwhile Japan is latest to reach reaches deal with Pfizer/BioNTech.
Sun’s Q1 earnings were dented by provisions related to the generic pricing investigation settlement with the US Department of Justice of arm Taro, and the impact of pandemic-related lockdowns. Some clinic-administered products bore the brunt of lock-downs in parts of the US, though market share was unaffected.